AUROBINDO PHARMA LTD

🚀 Exploring the Future of Pharma Manufacturing at CPHI & PMEC India 2024! On 26th-27th November 2024, at the India Expo Center (IEML), Greater Noida, Delhi NCR, we had an insightful session on Continuous Innovation & Agile Manufacturing for Next-Generation Therapeutics. Moderated by Dr. Mahesh Bhalgat, Group CEO & MD of Veeda Clinical Research Limited, this session featured a powerhouse panel of industry experts, including Atul Shastri, President of Operations at Eugia Pharma Specialities Ltd, a wholly owned subsidiary of AUROBINDO PHARMA LTD Atul shared his valuable insights during the discussion on “Redefining the Future of Pharma: Pharma Manufacturing Conclave.” The session focused on cutting-edge strategies to enhance agility and drive continuous improvement in pharma manufacturing — laying the foundation for the therapies of tomorrow. #CPHIIndia2024 #PharmaInnovation #AgileManufacturing Yugandhar Puvvala Vishal Arora

The PSCI - Pharmaceutical Supply Chain Initiative is committed to fostering a vision of excellence in safety, environmental, and social outcomes across global communities. Through its knowledge-driven conferences, PSCI continues to shape the future of sustainability and collaboration in the pharmaceutical supply chain.     This November, PSCI hosted its Fall Meeting (6–7 Nov 2024) in Germany, graciously hosted by Boehringer Ingelheim. The event brought together industry leaders, including the PSCI India Team and members from across the globe.     We are proud to share that Aurobindo Pharma, a full member of PSCI, actively participated in the event, and was represented by Dr. JVN Reddy (Director, Advisor – EHS).     Key highlights of the meeting included:   - Supplier Engagement   - Decarbonisation   - PSCI Modular Audit Framework and Projects   - Global Supplier Conference  - Panel Discussions & Workshops     At Aurobindo Pharma, we remain committed to advancing sustainable and ethical practices that align with PSCI’s vision for a better tomorrow.     #PSCI2024 #SustainabilityInPharma #AurobindoPharma #GlobalCollaboration #Decarbonisation #SupplierEngagement

Eugia Pharma Specialities Ltd is Hiring Quality Assurance Professionals! If you have the expertise and passion for quality assurance, we want to hear from you! Quality starts with you. Join us and make a difference! #Hiring #PharmaJobs #Pharmajobopenings #AurobindoPharmaLimited

Aurobindo Pharma arm inks $25-million licence deal with global player. Click the link to know more: https://lnkd.in/gYumi6X4

We are delighted to announce that Aurobindo Pharma Limited, Unit III has successfully received Regulatory Approval from the Eurasian Economic Union (EAEU) Pharmaceutical Inspectorate, Ministry of Industry and Trade of the Russian Federation.  This significant milestone follows the GMP Inspection conducted from 17th to 20th June 2024 by esteemed inspectors, Mr. Vladimir Igorevich Pavlov and Mr. Artem Vladimirovich Yakovlev.     The Approval/Registration Certificate was personally handed over by Mr. Deepak Singh, Country Head, Russia, and Ms. Olesya Morozova, Senior Manager, Regulatory Affairs, Russia, to:   Dr. A R M Rao, Quality Officer, Global Quality   Mr. Malineni Venkateswar Rao, Senior Vice President - Quality, Unit III   Mr. Kamaraj Abraham, Associate Vice President - QA, Unit III   Mr. Madhu Mvv, Senior Scientist, Regulatory Affairs, India     This achievement reflects our unwavering commitment to quality and compliance on a global scale.     #AurobindoPharma #QualityExcellence #GMPApproval #GlobalStandards

Eugia Pharma Specialities Limited – a wholly owned subsidiary of AUROBINDO PHARMA LTD – is steadfast in its mission to deliver high-quality generic sterile injectables, oncology, hormonal, and ophthalmic medicines. We are proud to have a strong presence in the USA, with expanding footprints across Europe and several emerging markets. Recently, Eugia marked another milestone by launching three oncology products in Australia, with many more products in the pipeline for approval over the next 12 months. Our Eugia Australia team actively participated in the Medicines Management 2024 Conference at the Adelaide Convention Center, hosted by Advanced Pharmacy Australia. This impactful event, held from November 14-16, brought together pharmacy professionals to discuss advancements and innovation in the industry. Yugandhar Puvvala Vijay Natarajan Abhishek Khadria Vyas Sandip #EugiaPharma #Pharmaceuticals #Oncology #Innovation #MedicinesManagement2024 #Australia

Aurobindo Pharma is dedicated to providing a supportive work culture and growth opportunities to employees. Dr UNB Raju Sr Vice President – HR, emphasizes the company's dedication to continuous training and skill development, stressing the importance of regularly upgrading employees' skills to remain competitive in an ever-changing industry. Click to listen to his perspective and the company's upcoming learning and development initiatives. #LifeAtAuro #AurobindoPharmaLtd #EmployeeSpotlight #Testimonials #Lifeinpharma

Aurobindo Pharma's subsidiary CuraTeQ Biologics has received a GMP certificate of compliance for its biosimilars manufacturing facility from the European Medicines Agency (EMA). Click to read the full article: https://lnkd.in/g77kBhka #PenicillinG #LyfiusPharma #AtmanirbharBharat #HealthcareInnovation #MadeInIndia

Aurobindo Pharma Q2 net profit rises 9%. Read more about our Q2 FY25 results: https://lnkd.in/g2KyF_HW

Dr. Vijayapal Reddy KanumathiReddy, Associate Vice President of Strategic Purchase at Aurobindo, has developed a well-rounded perspective by working on critical projects throughout his tenure. He credits Aurobindo’s collaborative culture and commitment to excellence for his continued growth and success. Tune in to hear directly from Dr. Vijaypal about his experiences and what Life@Auro looks like! #LifeAtAuro #AurobindoPharmaLtd #EmployeeSpotlight #Testimonials #Lifeinpharma